ly 117018 has been researched along with Osteoporosis, Postmenopausal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, L; Catalán, MP; De la Piedra, C; García-Moreno, C; Ortiz, A | 1 |
| Collishaw, S; Huber, C; Mosley, JR; Noble, BS; Reeve, J | 1 |
| Carlsten, H; Islander, U; Jochems, C; Kallkopf, A; Lagerquist, M; Ohlsson, C | 1 |
3 other study(ies) available for ly 117018 and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Modulation of survival in osteoblasts from postmenopausal women.
Topics: Aged; Apoptosis; Cell Survival; Cells, Cultured; Estradiol; Estrogens; fas Receptor; Female; Humans; Middle Aged; Osteoblasts; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Tumor Necrosis Factor-alpha | 2004 |
Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance.
Topics: Animals; Apoptosis; Bone and Bones; Bone Density; Cell Survival; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Humans; Osteocytes; Osteoporosis, Postmenopausal; Pyrrolidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Thiophenes; Treatment Outcome | 2007 |
Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis.
Topics: Animals; Arthritis; Arthritis, Experimental; Bone Density; Cytokines; Female; Humans; Mice; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Thiophenes; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |